To Construct Multi-Omics Modelfor Predicting Prognosis of Definitive Chemoradiotherapyin Locally Advanced Non-Small Cell Lung Cancer

被引:0
|
作者
Li, L. [1 ]
Song, X. [1 ]
Liu, N. [1 ]
Zhou, T. [1 ]
Yuan, S. [1 ,2 ]
机构
[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Jinan, Peoples R China
[2] Univ Sci & Technol China, Affiliated Hosp USTC 1, Div Life Sci & Med, Hefei, Anhui, Peoples R China
关键词
non-small cell lung cancer; definitive chemoradiotherapy; radiogenomics;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP.08C.03
引用
收藏
页码:S567 / S567
页数:1
相关论文
共 50 条
  • [31] Integrative Multi-Omics Analysis of Identified NUF2 as a Candidate Oncogene Correlates With Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer
    Chen, Mengqing
    Li, Shangkun
    Liang, Yuling
    Zhang, Yue
    Luo, Dan
    Wang, Wenjun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [32] Induction immunochemotherapy followed by definitive chemoradiotherapy for unresectable locally advanced non-small cell lung cancer: a multi-institutional retrospective cohort study
    Wu, Leilei
    Cheng, Bo
    Sun, Xiaojiang
    Zhang, Zhenshan
    Kang, Jingjing
    Chen, Yun
    Xu, Qinghua
    Yang, Shuangyan
    Yan, Yujie
    Ren, Shengxiang
    Zhou, Caicun
    Xu, Yaping
    MEDCOMM, 2024, 5 (03):
  • [33] Multi-Omics Uncovers Signatures Associated with Resistance to Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer Patients
    Braune, E. -B.
    Eide, I. J. Zwicky
    Grundberg, O.
    De Petris, L.
    Brustugun, O. T.
    Ekman, S.
    Hydbring, P.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S623 - S623
  • [34] Salvage Surgery After Definitive Chemoradiotherapy for Non-small Cell Lung Cancer
    Casiraghi, Monica
    Maisonneuve, Patrick
    Piperno, Gaia
    Bellini, Roberto
    Brambilla, Daniela
    Petrella, Francesco
    De Marinis, Filippo
    Spaggiari, Lorenzo
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2017, 29 (02) : 233 - 241
  • [35] Locally Advanced Non-Small Cell Lung Cancer: Optimal Chemotherapeutic Agents and Duration
    Hirva Mamdani
    Shadia I. Jalal
    Nasser Hanna
    Current Treatment Options in Oncology, 2015, 16
  • [36] Management of Oncogene Driven Locally Advanced Unresectable Non-small Cell Lung Cancer
    Loh, Jerold
    Low, Jia Li
    Sachdeva, Manavi
    Low, Peter Q. J.
    Wong, Rachel Su Jen
    Huang, Yiqing
    Chia, Puey Ling
    Soo, Ross A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (09) : 913 - 926
  • [37] Radiation therapy and combined treatment for locally advanced non-small cell lung cancer
    Martel-Lafay, I.
    ONCOLOGIE, 2016, 18 (06) : 385 - 391
  • [38] Treatment of locally advanced non-small cell lung cancer with combination of chemotherapy and radiation
    Martins, RG
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 26 (03) : 273 - 277
  • [39] Locally Advanced Non-Small Cell Lung Cancer: Optimal Chemotherapeutic Agents and Duration
    Mamdani, Hirva
    Jalal, Shadia I.
    Hanna, Nasser
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2015, 16 (10)
  • [40] Use of chemo-radiotherapy in locally advanced non-small cell lung cancer
    Novello, S
    Le Chevalier, T
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (02) : 292 - 299